Sun Pharmaceutical Industries rises on reporting 13% rise in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sun Pharmaceutical Industries is currently trading at Rs. 815.50, up by 3.75 points or 0.46% from its previous closing of Rs. 811.75 on the BSE.
The scrip opened at Rs. 816.75 and has touched a high and low of Rs. 835.90 and Rs. 783.00 respectively. So far 461069 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 850.00 on 18-Oct-2021 and a 52 week low of Rs. 459.30 on 02-Nov-2020.
Last one week high and low of the scrip stood at Rs. 838.40 and Rs. 779.00 respectively. The current market cap of the company is Rs. 198185.07 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.80% and 11.72% respectively.
Sun Pharmaceutical Industries has reported over 3-fold jump in its net profit at Rs 809.07 crore for second quarter ended September 30, 2021 as compared to Rs 223.70 crore for the same quarter in the previous year. Total income of the company increased by 22.49% at Rs 4427.42 crore for Q2FY22 as compared Rs 3614.53 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 12.92% in its net profit at Rs 2047.01 crore for second quarter ended September 30, 2021 as compared to Rs 1812.79 crore for the same quarter in the previous year. Total income of the company increased by 11.81 % at Rs 9,848.82 crore for Q2FY22 as compared Rs 8808.91 crore for the corresponding quarter previous year.
